PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARDX vs. DNA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ARDX and DNA is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

ARDX vs. DNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ardelyx, Inc. (ARDX) and Ginkgo Bioworks Holdings, Inc. (DNA). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%JulyAugustSeptemberOctoberNovemberDecember
-45.26%
-97.51%
ARDX
DNA

Key characteristics

Sharpe Ratio

ARDX:

-0.23

DNA:

-0.83

Sortino Ratio

ARDX:

0.23

DNA:

-1.82

Omega Ratio

ARDX:

1.03

DNA:

0.80

Calmar Ratio

ARDX:

-0.22

DNA:

-0.86

Martin Ratio

ARDX:

-0.58

DNA:

-1.23

Ulcer Index

ARDX:

32.57%

DNA:

69.09%

Daily Std Dev

ARDX:

81.79%

DNA:

102.64%

Max Drawdown

ARDX:

-98.45%

DNA:

-99.10%

Current Drawdown

ARDX:

-85.35%

DNA:

-98.31%

Fundamentals

Market Cap

ARDX:

$1.10B

DNA:

$552.37M

EPS

ARDX:

-$0.32

DNA:

-$12.89

Total Revenue (TTM)

ARDX:

$251.85M

DNA:

$217.95M

Gross Profit (TTM)

ARDX:

$213.48M

DNA:

$138.89M

EBITDA (TTM)

ARDX:

-$53.06M

DNA:

-$607.14M

Returns By Period

In the year-to-date period, ARDX achieves a -22.26% return, which is significantly higher than DNA's -85.09% return.


ARDX

YTD

-22.26%

1M

-2.03%

6M

-21.75%

1Y

-23.37%

5Y*

-9.88%

10Y*

-14.39%

DNA

YTD

-85.09%

1M

58.49%

6M

-40.62%

1Y

-85.68%

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ARDX vs. DNA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Ardelyx, Inc. (ARDX) and Ginkgo Bioworks Holdings, Inc. (DNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ARDX, currently valued at -0.23, compared to the broader market-4.00-2.000.002.00-0.23-0.83
The chart of Sortino ratio for ARDX, currently valued at 0.23, compared to the broader market-4.00-2.000.002.004.000.23-1.82
The chart of Omega ratio for ARDX, currently valued at 1.03, compared to the broader market0.501.001.502.001.030.80
The chart of Calmar ratio for ARDX, currently valued at -0.35, compared to the broader market0.002.004.006.00-0.35-0.86
The chart of Martin ratio for ARDX, currently valued at -0.58, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.58-1.23
ARDX
DNA

The current ARDX Sharpe Ratio is -0.23, which is higher than the DNA Sharpe Ratio of -0.83. The chart below compares the historical Sharpe Ratios of ARDX and DNA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50JulyAugustSeptemberOctoberNovemberDecember
-0.23
-0.83
ARDX
DNA

Dividends

ARDX vs. DNA - Dividend Comparison

Neither ARDX nor DNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ARDX vs. DNA - Drawdown Comparison

The maximum ARDX drawdown since its inception was -98.45%, roughly equal to the maximum DNA drawdown of -99.10%. Use the drawdown chart below to compare losses from any high point for ARDX and DNA. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%JulyAugustSeptemberOctoberNovemberDecember
-50.51%
-98.31%
ARDX
DNA

Volatility

ARDX vs. DNA - Volatility Comparison

The current volatility for Ardelyx, Inc. (ARDX) is 20.53%, while Ginkgo Bioworks Holdings, Inc. (DNA) has a volatility of 35.69%. This indicates that ARDX experiences smaller price fluctuations and is considered to be less risky than DNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%40.00%45.00%JulyAugustSeptemberOctoberNovemberDecember
20.53%
35.69%
ARDX
DNA

Financials

ARDX vs. DNA - Financials Comparison

This section allows you to compare key financial metrics between Ardelyx, Inc. and Ginkgo Bioworks Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab